1.  47
    A Pharmaceutical Bioethics Consultation Service: Six-Year Descriptive Characteristics and Results of a Feedback Survey.Luann E. Van Campen, Albert J. Allen, Susan B. Watson & Donald G. Therasse - 2015 - Ajob Empirical Bioethics 6 (2):53-62.
    Direct download (3 more)  
    Export citation  
    Bookmark   1 citation  
  2.  7
    Considerations for Applying Bioethics Norms to a Biopharmaceutical Industry Setting.Wendell Fortson, Kathleen Novak Stern, Curtis Chang, Angela Rossetti, Ariella Kelman, Michael Turik, Donald G. Therasse, Tatjana Poplazarova & Luann E. Van Campen - 2021 - BMC Medical Ethics 22 (1).
    BackgroundThe biopharmaceutical industry operates at the intersection of life sciences, clinical research, clinical care, public health, and business, which presents distinct operational and ethical challenges. This setting merits focused bioethics consideration to complement legal compliance and business ethics efforts. However, bioethics as applied to a biopharmaceutical industry setting often is construed either too broadly or too narrowly with little examination of its proper scope.Main textAny institution with a scientific or healthcare mission should engage bioethics norms to navigate ethical issues that (...)
    No categories
    Direct download (2 more)  
    Export citation